Society guideline links: Neuropathic pain

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: Neuropathy".)

●(See "Society guideline links: Radiculopathy".)

●(See "Society guideline links: Complex regional pain syndrome".)

●(See "Society guideline links: Cancer pain".)

●(See "Society guideline links: Chronic pain management".)

International

●Evidence-based consensus guidelines on patient selection and trial stimulation for spinal cord stimulation therapy for chronic non-cancer pain (2023)

●International Headache Society (IHS): International classification of orofacial pain, 1st edition (2020)

●International Association for the Study of Pain (IASP): Classification of chronic pain for ICD-11 – Chronic neuropathic pain (2019)

●World Health Organization (WHO): Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents (2019)

●IHS: International classification of headache disorders, 3rd edition (2018)

●IASP: Pharmacotherapy for neuropathic pain in adults – Systematic review, meta-analysis, and updated NeuPSIG recommendations (2015)

●International RDC/TMD Consortium Network and IASP: Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications (2014)

●IASP: Interventional management of neuropathic pain – NeuPSIG recommendations (2013)

●IASP: NeuPSIG guidelines on neuropathic pain assessment (2011)

Canada

●Cancer Care Ontario (CCO): Symptom management algorithm – Pain in adults with cancer

●CanPain SCI Working Group: Clinical practice guidelines for rehabilitation management of neuropathic pain after spinal cord injury, 2021 update (published 2022)

●Choosing Wisely Canada: Don't choose opioids or cannabinoids as the first choice of treatment for neuropathic pain (updated 2022)

●Medical Services Commission: BC guidelines for managing patients with pain in primary care – Part 1 (2022)

●Medical Services Commission: BC guidelines for managing patients with pain in primary care – Part 2 (2022)

●PEER simplified chronic pain guideline – Management of chronic low back, osteoarthritic, and neuropathic pain in primary care (2022)

●CCO: Guidelines on management of pain in cancer and/or palliative care (2017)

●Medical Services Commission: BC guidelines on palliative care for the patient with incurable cancer or advanced disease − Part 2: Pain and symptom management (2017)

●Canadian Pain Society (CPS): Revised consensus statement for the pharmacological management of chronic neuropathic pain (2014)

●CPS: Evidence-based guideline for neuropathic pain interventional treatments − Spinal cord stimulation, intravenous infusions, epidural injections and nerve blocks (2012)

●Toronto Consensus Panel on Diabetic Neuropathy: Painful diabetic peripheral neuropathy – Consensus recommendations on diagnosis, assessment and management (2011)

United States

●American College of Radiology (ACR): ACR Appropriateness Criteria on cranial neuropathy (2022)

●Centers for Disease Control and Prevention (CDC): Clinical practice guideline for prescribing opioids for pain (2022)

●Society for Integrative Oncology (SIO) and American Society of Clinical Oncology (ASCO): Guideline on integrative medicine for pain management in oncology (2022)

●American Academy of Neurology (AAN): Assessment – Efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review) (2010, reaffirmed 2021)

●AAN: Oral and topical treatment of painful diabetic polyneuropathy – Practice guideline update (2021)

●AAN: Practice advisory – Utility of surgical decompression for treatment of diabetic neuropathy (2006, reaffirmed 2021)

●AAN and European Federation of Neurological Societies (EFNS): Practice parameter – The diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review) (2008, reaffirmed 2021)

●Congress of Neurological Surgeons (CNS): Systematic review and evidence-based guideline on neuroablative procedures for patients with cancer pain (2021)

●ASCO: Clinical practice guideline for the prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers (2020)

●American Society of Regional Anesthesia and Pain Medicine (ASRA), American Academy of Pain Medicine (AAPM), and American Society of Anesthesiologists (ASA): Consensus guidelines on the use of intravenous ketamine infusions for chronic pain (2018)

●Infectious Diseases Society of America (IDSA): Clinical practice guideline for the management of chronic pain in patients living with HIV (2017)

●ASCO: Clinical practice guideline for the management of chronic pain in survivors of adult cancers (2016)

●CNS: Systematic review and evidence-based guideline on occipital nerve stimulation for the treatment of patients with medically refractory occipital neuralgia (2015)

●Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain (2011)

Europe

●American Academy of Neurology (AAN) and European Federation of Neurological Societies (EFNS): Practice parameter – The diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review) (2008, reaffirmed 2021)

●European Society for Medical Oncology (ESMO)-European Oncology Nursing Society (EONS)-European Association of Neuro-Oncology (EANO): Systemic anticancer therapy-induced peripheral and central neurotoxicity – Clinical practice guidelines for diagnosis, prevention, treatment and follow-up (2020)

●European Academy of Neurology (EAN): Guideline on trigeminal neuralgia (2019)

●European Headache Federation (EHF): Aids to management of headache disorders in primary care, 2nd edition (2019)

●ESMO: Clinical practice guidelines for the management of cancer pain in adult patients (2018)

●EAN: Guidelines on central neurostimulation therapy in chronic pain conditions (2016)

●EFNS: Guidelines on neuropathic pain assessment, revised 2009 (published 2010)

●EFNS: Guidelines on the pharmacological treatment of neuropathic pain, revision (2010)

United Kingdom

●National Health Service Scotland (NHS Scotland): Scottish palliative care guidelines on neuropathic pain (2014, updated 2022)

●National Institute for Health and Care Excellence (NICE): Interventional procedures guidance for stereotactic radiosurgery for trigeminal neuralgia (2022)

●NICE: Clinical guideline on neuropathic pain in adults – Pharmacological management in non-specialist settings (2013, updated 2020)

●NICE: Medical technologies guidance for Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain (2019)

●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline for management of chronic pain (2013, revised 2019)

●NICE: Interventional procedures guidance for transcranial MRI-guided focused ultrasound thalamotomy for neuropathic pain (2018)

●NICE: Interventional procedures guidance for percutaneous electrical nerve stimulation for refractory neuropathic pain (2013)

Australia–New Zealand

●Australian and New Zealand College of Anaesthetists (ANZCA): Statement regarding the use of opioid analgesics in patients with chronic non-cancer pain (2021)

●Cancer Council Australia (CCA): Clinical guidelines for cancer pain management in adults (updated 2019)

●Choosing Wisely Australia: Avoid prescribing pregabalin and gabapentin for pain which does not fulfil the criteria for neuropathic pain (2018)

●Western Australian Therapeutic Advisory Group (WATAG): Guidelines for the pharmacological treatment of neuropathic pain (2017)

Japan

●[In English] Japanese Society for Palliative Medicine (JSPM): Clinical guidelines on pharmacological treatment recommendations for cancer pain, revision (2022)

●[In English] Japan Society of Acupuncture and Moxibustion (JSAM), Japanese Association for the Study of Musculoskeletal Pain (JASMP), Japanese Society of Orofacial Pain (JSOP), Japanese Headache Society (JHS), Japan College of Fibromyalgia Investigation (JCFI), Japanese Association for the Study of Pain (JASP), Japan Society of Pain Clinicians (JSPC), Japanese Association for the Study of Pain Rehabilitation (JASPR), Japanese Society for the Study of Chronic Pain (JSSCP), Japanese Society for the Study of Low Back Pain (JSSLBP): Clinical practice guidelines for the management of chronic pain (2021)

●[In Japanese] JSPM: Clinical guidelines for cancer pain management, 3rd edition (2020)

●[In Japanese] Japanese Association of Supportive Care in Cancer (JASCC): Clinical guide of management for chemotherapy-induced peripheral neuropathy (2017)

●[In English] JSPC: Guidelines for the pharmacologic management of neuropathic pain, 2nd edition (2016)

●[In Japanese] JSPC: Guidelines for the pharmacologic management of neuropathic pain, 2nd edition (2016)